Silence Therapeutics (SLN)
(Delayed Data from NSDQ)
$4.89 USD
-0.14 (-2.78%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $5.00 +0.11 (2.25%) 7:48 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Silence Therapeutics PLC Sponsored ADR's dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
SLN 4.89 -0.14(-2.78%)
Will SLN be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for SLN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SLN
Beat the Market the Zacks Way: Credo, Palantir, Oracle in Focus
Wall Street Analysts Think Silence Therapeutics (SLN) Could Surge 556.19%: Read This Before Placing a Bet
SLN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts Believe Silence Therapeutics (SLN) Could Rally 590.66%: Here's is How to Trade
Silence Therapeutics (SLN) Upgraded to Buy: Here's What You Should Know
SLN Stock Down Despite Cholesterol Drug Lowering Lipoprotein Levels
Other News for SLN
SLN forms MACD Bullish Signal Line Cross on September 19
Directional Movement Crossover Bullish appears for SLN after 3.3% move
Stochastic Buy Signal appears for SLN after 2.54% move
Lower Bollinger Band Walk appears for SLN after 4.88% move
Silence Therapeutics (SLN) Receives Reiterated Buy Rating from HC Wainwright | SLN Stock News